577 studies found for:    chelation
Show Display Options
Rank Status Study
1 Completed Trial to Assess Chelation Therapy (TACT)
Condition: Coronary Artery Disease
Interventions: Drug: EDTA chelation therapy;   Drug: Placebo infusions
2 Completed Effects of Iron Loading and Iron Chelation Therapy on Innate Immunity During Human Endotoxemia
Conditions: Systemic Inflammation;   Iron Loading;   Iron Chelation
Interventions: Drug: iron sucrose;   Drug: Deferasirox;   Drug: endotoxin;   Drug: Placebo
3 Active, not recruiting Combo Chelation Trial
Conditions: Thalassemia;   Iron Overload
Intervention: Drug: Combo Chelation with Deferasirox (Exjade) and Desferal (DFO)
4 Completed Combination Iron Chelation Therapy
Conditions: Iron Overload;   Thalassemia
Intervention: Drug: Combination Iron Chelation Therapy
5 Completed Iron-Chelating Therapy and Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Iron chelating intervention
6 Completed Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
Condition: Urologic Disease
Intervention: Drug: calcium disodium EDTA (edetate calcium disodium)
7 Withdrawn Penicillamine Chelation for Children With Lead Poisoning
Conditions: Lead Poisoning;   Vitamin D Deficiency
Interventions: Device: d-penicillamine;   Drug: placebo
8 Completed Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
Conditions: Iron Overload;   Cardiomyopathy
Interventions: Drug: Deferoxamine and Deferiprone;   Drug: Deferoxamine
9 Unknown  Environmental Exposure to Lead and Its Health Effects on Patients With Maintenance Hemodialysis
Conditions: Anemia;   Malnutrition;   Inflammation;   Lead Poisoning
Intervention: Drug: lead chelation therapy
10 Completed Mercury Chelation to Treat Autism
Conditions: Autism;   Asperger's Disorder;   Child Development Disorders, Pervasive
Intervention: Drug: DMSA
11 Completed
Has Results
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
Conditions: Anemia;   Hemosiderosis
Intervention: Drug: Deferasirox
12 Completed
Has Results
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload in β-thalassemia
Intervention: Drug: Deferasirox
13 Terminated
Has Results
Stroke With Transfusions Changing to Hydroxyurea
Conditions: Hemochromatosis;   Cerebrovascular Accident;   Anemia, Sickle Cell;   Hematologic Diseases
Interventions: Procedure: Red Cell Transfusions;   Procedure: Iron Chelation;   Drug: Hydroxyurea;   Procedure: Phlebotomy
14 Completed Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
Conditions: Anemia (Iron-Loading);   Beta-Thalassemia;   Hematologic Diseases;   Hemoglobinopathies;   Thalassemia;   Iron Overload
Intervention: Drug: chelation therapy
15 Completed Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload
Intervention: Drug: Deferasirox
16 Completed Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload
Conditions: Myelodysplastic Syndromes;   Transfusion Dependent Iron Overload
Intervention: Drug: ICL670/Deferasirox
17 Completed Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Condition: Iron Overload
Intervention: Drug: Deferasirox
18 Completed Sickle Cell Disease: A Retrospective Chart Review
Condition: Sickle Cell Anemia
Intervention:
19 Unknown  Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
Condition: Beta-Thalassemia
Intervention: Drug: deferiprone
20 Completed Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Conditions: Myelodysplastic Syndrome;   Iron Overload
Intervention: Drug: Deferasirox

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years